Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500, Nasdaq set for higher open as investors weigh weaker oil, PPI data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Akcea Reports Financial Results and Highlights for First Quarter 2019
May 8, 2019 4:07 PM EDTAchieved First Quarter 2019 TEGSEDI® (inotersen) Global Net Product Revenues of $7 Million
 Novartis exercised its option to license AKCEA-APO(a)-LRx
Received marketing authorization for WAYLIVRA® (volanesorsen) in E.U.
Conference Call Webcast Wednesday, May 8, 4:30 p.m. ET... More
